High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam-Reference-Cited by-同舟云学术

High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam

Published:2020-02-10 Issue:6 Volume:75 Page:1650-1651
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Periasamy Hariharan¹,Joshi Prashant¹,Palwe Snehal¹,Shrivastava Rahul¹,Bhagwat Sachin¹,Patel Mahesh¹

Affiliation:

1. Drug Discovery Research, Wockhardt Research Center, Aurangabad, Maharashtra, India

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/75/6/1650/33213968/dkaa021.pdf

Reference11 articles.

1. Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3;Alm;J Antimicrob Chemother,2015

2. Unusual Escherichia coli PBP3 insertion sequence identified from a collection of carbapenem-resistant Enterobacteriaceae tested in vitro with a combination of ceftazidime-, ceftaroline-, or aztreonam-avibactam;Zhang;Antimicrob Agents Chemother,2017

3. Antimicrobial activities of aztreonam-avibactam and comparator agents against contemporary (2016) clinical Enterobacteriaceae isolates;Sader;Antimicrob Agents Chemother,2018

4. In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against OXA-48-carrying Enterobacteriaceae isolated as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance program from 2012 to 2015;Kazmierczak;Antimicrob Agents Chemother,2018

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular targets and pharmacodynamics for bactericidal and bacteriostatic activity;Nanotechnology Tools for Infection Control;2025

2. Development and validation of a pentaplex PCR assay for rapid detection of blaCTX-M, blaOXA–1, blaCMY, blaNDM and the PBP3 insert in Enterobacterales;Indian Journal of Medical Microbiology;2024-11

3. Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability;International Journal of Antimicrobial Agents;2024-09

4. Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa : insights from the hollow-fiber infection model;Infectious Diseases;2024-08-30

5. Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol;Microbiology Spectrum;2024-07-02